Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study

Juan Valle, Daniel Palmer, Richard Jackson, Trevor Cox, John Neoptolemos, Paula Ghaneh, Charlotte Rawcliffe, Claudio Bassi, Deborah Stocken, David Cunningham, Derek O'Reilly, David Goldstein, Bridget Robinson, Christos Karapetis, Andrew Scarfe, Francois Lacaine, Juhani Sand, Jakob Izbicki, Julia Mayerle, Christos DervenisAttila Olah, Giovanni Butturini, Pehr Lind, Mark Middleton, Alan Anthoney, Kate Sumpter, Ross Carter, Markus Buchler

    Research output: Contribution to journal › Article › peer-review

    349 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study'. Together they form a unique fingerprint.

    Medicine and Dentistry